Galderma’s Epiduo Gel approved for the treatment of acne in Japan

Lausanne, July 5, 2016 – Galderma, Nestlé Skin Health’s medical solutions business, today announced that Japan’s Ministry of Health, Labor and Welfare has approved Epiduo, a novel topical treatment for acne vulgaris in Japan. Since its first marketing authorization in 2007, Epiduo has now been approved in over 60 countries around the world for the treatment of acne vulgaris, and is the most prescribed topical acne medication in the world. Read more on Galderma.com

The release as fetched from its publisher. galderma.com ↗